Type Whole antibody Target α-fetoprotein CAS Number 476413-07-7 | ATC code none ChemSpider none | |
 | ||
Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer. The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
References
Yttrium (90Y) tacatuzumab tetraxetan Wikipedia(Text) CC BY-SA